Phase II evaluation of fludarabine in patients with metastatic breast cancer: A Southeastern Cancer Study Group trial

J. T. Carpenter, Charles Vogel, G. Wang, M. Raney

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)1235-1236
Number of pages2
JournalCancer Treatment Reports
Volume70
Issue number10
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Arabinonucleotides
Antineoplastic Antimetabolites
Vidarabine Phosphate
Drug Evaluation
Hematologic Diseases
Gastrointestinal Diseases
Clinical Trials
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
fludarabine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phase II evaluation of fludarabine in patients with metastatic breast cancer : A Southeastern Cancer Study Group trial. / Carpenter, J. T.; Vogel, Charles; Wang, G.; Raney, M.

In: Cancer Treatment Reports, Vol. 70, No. 10, 01.01.1986, p. 1235-1236.

Research output: Contribution to journalArticle

@article{744940b1f6834f9dbcad18449d60c0c8,
title = "Phase II evaluation of fludarabine in patients with metastatic breast cancer: A Southeastern Cancer Study Group trial",
author = "Carpenter, {J. T.} and Charles Vogel and G. Wang and M. Raney",
year = "1986",
month = "1",
day = "1",
language = "English",
volume = "70",
pages = "1235--1236",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Phase II evaluation of fludarabine in patients with metastatic breast cancer

T2 - A Southeastern Cancer Study Group trial

AU - Carpenter, J. T.

AU - Vogel, Charles

AU - Wang, G.

AU - Raney, M.

PY - 1986/1/1

Y1 - 1986/1/1

UR - http://www.scopus.com/inward/record.url?scp=0022454374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022454374&partnerID=8YFLogxK

M3 - Article

C2 - 2428493

AN - SCOPUS:0022454374

VL - 70

SP - 1235

EP - 1236

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 10

ER -